"Efficacity of dupilumab in severe idiopathic cold urticaria: a case report." Journal of Dermatological Treatment, 34(1), pp.
Disclosure statement
Ziad Reguiai received honoraria from Sanofi and Novartis as a speaker, advisor and investigator in clinical trials.
Data availability statement
The data that support the findings of this study are available from the corresponding author, Z. Reguiai, upon reasonable request.
Additional information
Funding
The author(s) reported there is no funding associated with the work featured in this article.